Novartis Sees 15% Global Sales Growth and Significant Investment in China for 2006
Novartis (NYSE: NVS), a multinational pharmaceutical giant, has reported a robust sales revenue of nearly...
Ruijin Hospital Researchers Uncover Five New Mutations in Rare 17OHD Endocrine Disorder
In a significant advancement in endocrine research, scientists within the Endocrine Department at Ruijin Hospital...
China’s SFDA Mandates Official Position Rotation to Boost Transparency
China’s State Food and Drug Administration (SFDA) is poised to embrace a new era of...
Guangdong’s ‘Sunlight Purchase’ System Sparks Drug Pricing War and Uncovers Pricing Anomalies
Since 2007, Guangdong province’s medical facilities have utilized an online procurement system known as “Sunlight...
Ruijin Hospital Unveils Five New Mutations in Rare Adrenal Hyperplasia Study
In a groundbreaking study, Ruijin Hospital’s Endocrine Department researchers identified five novel mutations in 17...
SFDA Embraces Transparency: Regular Press Briefings and Personnel Rotations Announced
China’s State Food and Drug Administration (SFDA) is gearing up for a transparency overhaul, with...
China’s Western Pharmaceutical Exports Soar 23% in 2006, Led by Antibiotics
The China Chamber of Commerce for Import and Export of Medicines and Health Products (CCCMHPIE)...
Shanghai Roche Pharmaceuticals Launches Erlotinib for Advanced Non-Small Cell Lung Cancer in China
Shanghai Roche Pharmaceuticals Ltd. made headlines in March with the launch of its lung cancer...